Daniel V.T. Catenacci

17.1k citations
167 papers · 6.9k · 6 hit papers · h-index 37

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Gastrointestinal Tumor Research and Treatment

Papers in

    • Cancer Immunotherapy and Biomarkers 27
    • Colorectal Cancer Treatments and Studies 25
    • Pancreatic and Hepatic Oncology Research 19
    • Gastric Cancer Management and Outcomes 62

Daniel V.T. Catenacci

161 papers receiving 6.9k citations

Daniel V.T. Catenacci's Hit Papers

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study 2020 · 1.0k citations
1.0k0+4+8Years since publication2505007501000

Peers

Daniel V.T. Catenacci
Comparison fields: 5 of 101
  • Oncology 3.3k
  • Gastroenterology 461
  • Pulmonary and Respiratory Medicine 2.2k
  • Cancer Research 1.0k
  • Surgery 2.4k
Replace Yoshito Komatsu with:
Yoshito Komatsu Japan
Vladimir Moiseyenko Russia
Joan Maurel Spain
Alexa B. Schrock United States
Christelle de la Fouchardière France
Catherine Delbaldo France
Rachna T. Shroff United States
Magali Svrcek France
Samuel J. Klempner United States
Yo Kato Japan
Daniel V.T. Catenacci relative to Yoshito Komatsu Japan Yoshito Komatsu's profile →
Citations per field
00.5×1.5×1.8×
Yoshito Komatsu · 1×
Citations per year

Countries citing papers authored by Daniel V.T. Catenacci

Since Specialization
Citations

This map shows the geographic impact of Daniel V.T. Catenacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel V.T. Catenacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel V.T. Catenacci more than expected).

Fields of papers citing papers by Daniel V.T. Catenacci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel V.T. Catenacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel V.T. Catenacci. The network helps show where Daniel V.T. Catenacci may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel V.T. Catenacci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel V.T. Catenacci Line = papers co-authored together Daniel V.T. Catenacci links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Hit paper breakdown →
20201012
2
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Hit paper breakdown →
2016854
3
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
Hit paper breakdown →
2019455
4
New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing
Hit paper breakdown →
2014346
5
Biliary cancer: Utility of next‐generation sequencing for clinical management
Hit paper breakdown →
2016295
6 2019191
7
Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline
Hit paper breakdown →
2020189
8 2015185
9 2013182
10 2019153
11 2020128
12 2017127
13 2015119
14 201499
15 201183
16 201882
17 202082
18 202074
19 201969
20 201568

About Daniel V.T. Catenacci

Daniel V.T. Catenacci is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Molecular Biology, having authored 167 papers that have together received 6.9k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (62 papers), Cancer Genomics and Diagnostics (31 papers), Cancer Immunotherapy and Biomarkers (27 papers), Colorectal Cancer Treatments and Studies (25 papers), Gastrointestinal Tumor Research and Treatment (25 papers), Pancreatic and Hepatic Oncology Research (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Esophageal Cancer Research and Treatment (17 papers). The work is most often cited by research in Oncology (3.3k citations), Gastroenterology (461 citations), Pulmonary and Respiratory Medicine (2.2k citations), Cancer Research (1.0k citations) and Surgery (2.4k citations). Daniel V.T. Catenacci has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Hyun Cheol Chung, Yung‐Jue Bang, Siraj M. Ali, Jeffrey S. Ross, Kei Muro, Do‐Youn Oh, Talia Golan, Adrian Murphy, Eric Van Cutsem and Mitesh J. Borad. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Oncologist, Clinical Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact